SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001762003-19-000004
Filing Date
2019-02-05
Accepted
2019-02-05 10:03:51
Documents
1
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 3534
  Complete submission text file 0001762003-19-000004.txt   5073
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 ARLINGTON STREET BOSTON MA 02116
Business Address 75 ARLINGTON STREET BOSTON MA 02116 617-338-1700
Boston Foundation, Inc. (Reporting) CIK: 0001762003 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 0630
Type: 5 | Act: 34 | File No.: 001-36812 | Film No.: 19566582